课题基金 / 基金详情

The role of glomerular endothelial cell and accelerated regenerative factors in renal injur

The role of glomerular endothelial cell and accelerated regenerative factors in renal injur
肾小球内皮细胞及加速再生因子在肾损伤中的作用
批准号:
20591283
负责人:
KAWASAKI Yukihiko
金额:
$2.91万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

KAWASAKI Yukihiko的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了HUS小鼠肾脏恢复的过程及其与血管内皮生长因子、血管生成素-1的关系。将C57BL/6小鼠随机分为3组。第1组小鼠按30 0μg/kg和2 2 5 ng/kg Stx2剂量腹腔注射脂多糖,第2组小鼠按10 0μg/kg和10 0 ng/kg Stx2小剂量腹腔注射脂多糖。对照组小鼠接种生理盐水。每组5只小鼠于给药后随时间处死取肾进行组织学评价。第1组小鼠血清CRS水平高于第2组,第1组小鼠72~80h全部死亡,第2组小鼠全部存活。两组均可见红细胞碎裂。2组大鼠肾小球系膜细胞增殖、系膜基质表达、CD31阳性表达均高于1组。肾小球血管内皮生长因子和血管生成素-1的表达逐渐增强,72小时至7天达高峰。小剂量内毒素和Stx2诱导的HUS小鼠是急性肾损伤恢复过程中有用的模型,而血管内皮生长因子和血管生成素-1在其恢复过程中起重要作用。
英文摘要
We examined the process of the renal recovery in mice with HUS and the relationship between its renal recovery and VEGF, Angiopoietin-1. C57BL/6 mice were divided into three groups. Group 1 was consisted of mice received an inyraperitoneal injection of dose of LPS at 300 μ g/kg and 225 ng/kg Stx2, Group 2 was consisted of mice received an inyraperitoneal injection of a low dose of LPS at 100 μ g/kg and 100 ng/kg Stx2. Mice in the control group were inoculated with saline. The kidneys were extirpated from 5 mice of each group sacrificed with time after administration for histological evaluation. Serum Crs in Group 1 were higher than those in Group 2 and all mice in Group 1 were died at 72-80 hours and all mice in Group 2 were alive. The fragmented erythrocytes were found in both groups. Endothelial injury and mesangiolysis scores at 24 hours in Group 1 were higher than those in Group 2. In addition, mesangial proliferation and mesangial matrix scores, CD31 positive expression at 72 hours in Group 2 were higher than those in Group 1. Glomerular VEGF and Angiopoietin-1 expressing in Group 2 gradually increased and were peak from 72 hours to 7 days. HUS mice induced by low dose of LPS and Stx2 were useful model for the recovery process of acute renal injury and VEGF and Angiopoietin-1 play important roles of its recovery process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s00467-008-0749-6
发表时间: 2008-06-01
期刊: PEDIATRIC NEPHROLOGY
影响因子: 3
作者: [Kawasaki, Yukihiko, Imaizumi, Tomoko, Hosoya, Mitsuaki]
通讯作者: Hosoya, Mitsuaki
Tonsillectomy with methylprednisolone pulse therapy as rescue treatment for steroid- resistant IgA nephropathy in children
扁桃体切除术联合甲基强的松龙脉冲疗法作为儿童类固醇抵抗性 IgA 肾病的挽救治疗
DOI: --
发表时间: 2009
期刊: Tohoku J.Exp.Med. 218(1)
影响因子: --
作者: [Kawasaki Y, Suyama K, Abe Y, Ushijima Y, Sakai N, Takano K, Ito M, Hashimoto K, Hosoya M]
通讯作者: Hosoya M
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [川崎幸彦, 陶山和秀, 今泉智子, 大原信一郎, 高野恵, 鈴木重雄, 鈴木順造, 細矢光亮]
通讯作者: 細矢光亮
DOI: 10.1155/2009/681482
发表时间: 2009
期刊: Clinical & developmental immunology
影响因子: --
作者: [Kawasaki Y]
通讯作者: Kawasaki Y
共 22 条
    The control and the role of DAMPs in acute and chronic renal injury
    • 批准号:
      26461615
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2014
    • 负责人:
      KAWASAKI Yukihiko
    • 依托单位:
    The role of M1, M2 macrophage and regenerative factors in renal injury and recovery process
    • 批准号:
      23591575
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      KAWASAKI Yukihiko
    • 依托单位:
    腎糸球体の再生過程における糸球体内皮細胞の役割に関する検討
    • 批准号:
      17591103
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.35万
    • 财政年份:
      2005
    • 负责人:
      KAWASAKI Yukihiko
    • 依托单位:
    国内基金
    海外基金
    协同靶向VE-PTP/VEGF重建胶质母细胞瘤血管稳态的双靶点抑制剂开发与机制研究
    • 批准号:
      JCZRLH202601503
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于VEGF/VEGFR信号通路探讨自拟创疡膏对慢性创面的作用机制研究
    • 批准号:
      2026JJ80680
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      姜平
    • 依托单位:
    RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
    • 批准号:
      2026JJ80684
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      龚攀
    • 依托单位: